ClinicalTrials.Veeva

Menu

Novel Approaches to Reducing Tobacco Related Harm

Duke University logo

Duke University

Status

Completed

Conditions

Cigarette Smoking
Tobacco Smoking Behavior
Smoking

Treatments

Other: Electronic cigarettes 2
Other: Electronic cigarettes 1
Other: Usual brand cigarettes
Other: Lower nicotine content cigarettes

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT02600273
Pro00067757
5P30AI064518 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to assess initial reactions to alternative nicotine/tobacco products among smokers living with HIV.

Full description

Participants will sample 4 alternative nicotine/tobacco products and provide initial reactions to the products.

Enrollment

18 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. HIV-infected adults age 18 and older currently receiving HIV care
  2. Self-report smoking ≥10 cigarettes/day of a brand delivering >0.5mg nicotine for >2yrs
  3. Have afternoon expired CO concentrations of ≥10ppm or morning urinary cotinine >100ng/ml (as measured with NicAlert)

Exclusion criteria

  1. Impaired mental status as assessed by observation
  2. Acute intoxication as measured by breath alcohol level (BAL) > 0
  3. Current use of nicotine replacement or other pharmacotherapy for smoking cessation
  4. Previous use of e-cigarettes
  5. Use of other tobacco products (e.g., chew tobacco, cigars) on > 10 of the past 30 days
  6. Unstable HIV or associated comorbidities, as determined by a licensed medical professional.
  7. Pregnancy (Females testing positive for pregnancy and any participants wishing to quit immediately will be referred to community smoking cessation treatment and will be excluded from the study)
  8. Blood pressure at or above 160/100 or below 90/50
  9. Heart rate at or above 105 bpm or below 45 bpm

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

18 participants in 4 patient groups

Usual brand cigarettes
Active Comparator group
Description:
During one session, participants will smoke their usual brand cigarettes
Treatment:
Other: Usual brand cigarettes
Lower nicotine content cigarettes
Experimental group
Description:
During one session, participants will smoke SPECTRUM Research Cigarettes
Treatment:
Other: Lower nicotine content cigarettes
Electronic cigarettes 1
Experimental group
Description:
During one session, participants will use an electronic cigarette with 0 mg/mL nicotine e-liquid
Treatment:
Other: Electronic cigarettes 1
Electronic cigarettes 2
Experimental group
Description:
During one session, participants will use an electronic cigarette with 18 mg/mL nicotine e-liquid
Treatment:
Other: Electronic cigarettes 2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems